Soleno Therapeutics Inc (NASDAQ: SLNO) — Healthcare · Share Price, Chart & Market Data
About: Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $52.72 (-0.21%)
SLNOSoleno Therapeutics Inc
Loading watchlist status…
Trade SLNO now
Soleno Therapeutics Inc share price
SLNO price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:30 am GMT+0
SLNO price performance
0.095%
5D
68.22%
1M
11.766%
YTD
-28.978%
1Y
SLNO price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:30 am GMT+0
SLNO details
SLNO Market Signals